NeoStem is focused on developing and building on its core capabilities in cell therapy, to capitalize on the burgeoning cell therapy industry as well as cell therapy’s future role in the fight against chronic disease; the company also desires to … Continue reading →

Cleveland BioLabs is a clinical-stage biotechnology company focused on leveraging deep mechanistic understanding of apoptosis – the cell death process – to develop a strong pipeline of compounds chiefly focused on oncology applications and mitigation of radiation injury. The company’s … Continue reading →

Zealand Pharma is a Copenhagen, Denmark-based biotechnology company specializing in the discovery, optimization and development of novel peptide drugs. The company has an expansive and mature pipeline of drug candidates that have been identified through its own drug discovery activities. … Continue reading →

Biotie Therapies is a specialized drug development company engaged in the development of drugs to address diseases of high unmet medical need and significant market potential, including neurodegenerative and psychiatric disorders and inflammatory and fibrotic liver disease. The company’s development … Continue reading →

Cytokinetics is a clinical-stage biopharmaceutical company engaged in discovering and developing novel small molecule therapeutics that modulate muscle function to potentially treat serious diseases and medical conditions. The company has various drug candidates at different stages of clinical development, some … Continue reading →

ProMetic Life Sciences is a worldwide biopharmaceutical company that specializes in designing small molecules that mimic unique and specific interactions between proteins, research, development, manufacturing and marketing of various commercial applications derived from its proprietary Mimetic Ligand technology. The company … Continue reading →

Atossa Genetics, known as The Breast Health Company, is engaged in the prevention of breast cancer through commercializing patented, FDA-approved diagnostic medical devices and patented, laboratory-developed tests for detecting precursors to breast cancer up to eight years before mammography. The … Continue reading →

Targacept is a clinical-stage biopharmaceutical company engaged in developing a varied pipeline of innovative NNR therapeutics for hard-to-treat nervous system diseases and disorders. The company’s clinical pipeline includes multiple Phase 2 product candidates that all represent first-in-class opportunities, and Targacept … Continue reading →

  Provectus Pharmaceuticals is a biopharmaceutical company specializing in the development of oncology and dermatology therapies. PV-10, the company’s novel oncology drug, is designed to selectively target and destroy cancer cells without harming the surrounding healthy tissue. Provectus has received … Continue reading →

NovaBay Pharmaceuticals is a biotechnology company engaged in using its two distinct categories of product offerings – Aganocides and NeutroPhase Skin and Wound Cleanser – to address the large, unmet therapeutic needs of the worldwide anti-infective market. The company has … Continue reading →